👤 Guoxiang Li

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧪 BiometalDB 🧬 Extraction
3991
Articles
2551
Name variants
Also published as: Xiaocun Li, Jianyu Li, Xinzhi Li, Guanqiao Li, Zequn Li, Guang-Xi Li, Yubo Li, Bugao Li, Qingchao Li, Xikun Li, Hong-Tao Li, Guobin Li, Xihao Li, Rongqing Li, Chang-Da Li, Meng-Yue Li, DaZhuang Li, Shunqin Li, Jiajie Li, Yaqiong Li, Yuan-hao Li, Yongmei Li, X Y Li, Peilin Li, Ran Li, Chunshan Li, Yixiang Li, Guanglve Li, Ye Li, Zili Li, Yihao Li, Qing Run Li, Liling Li, Meng-Yang Li, Ziyun Li, Jun-Ying Li, Xinhai Li, Yongjiang Li, Wanru Li, Wenhao Li, Shisheng Li, Sai Li, Guangwen Li, Hua Li, Dongmei Li, Jiayang Li, Zunjiang Li, Minglong Li, Wenzhe Li, Zihan Li, Jin-Long Li, Hongxin Li, Caiyu Li, Fa-Hui Li, Guangpu Li, Teng Li, Wen-Jie Li, Hegen Li, Ang Li, Zhizong Li, Lu-Yun Li, Peng Li, Shiyu Li, Fang Li, Jiuke Li, Miyang Li, Mingxu Li, Chen-Xi Li, Panlong Li, Changwei Li, Biyu Li, Yaoqi Li, San-Feng Li, Jiaming Li, Jiyuan Li, Rongkai Li, Yani Li, Linke Li, C Y Li, Thomas Li, Siting Li, Yongnan Li, Jinchen Li, Jin-Ping Li, Xuewen Li, R Li, Xianlong Li, Aixin Li, Xuening Li, Guang Li, Xiaoming Li, Z-H Li, Yongli Li, Baohong Li, Shuyuan Li, L Li, Yuanmei Li, Yanwu Li, Hualing Li, Sibing Li, Xining Li, Qinghe Li, Zonghua Li, Liqin Li, Jingya Li, Youjun Li, Zheng-Dao Li, Zhenshu Li, Heng-Zhen Li, Yuhui Li, Wen-Ying Li, Wei Li, Shuanglong Li, Fei-feng Li, Letai Li, Kangli Li, Ming Li, Wenbo Li, Runwen Li, Yarong Li, Weidong Li, S E Li, Xin-Tao Li, Ruotong Li, Shuguang Li, Xiuzhen Li, Lingxi Li, Chuan-Hai Li, Tingting Li, Guanghua Li, Zhongyu Li, Zhen-Yu Li, Deyu Li, Hansen Li, Jinzhi Li, Yijing Li, Kaifeng Li, Wen-Xing Li, Qintong Li, Naishi Li, Xin-Ping Li, Han-Ni Li, Jiaying Li, Cui-lan Li, Ruonan Li, Jun-Jie Li, Shuhao Li, Ruitong Li, Suyan Li, Gen-Lin Li, Dianjie Li, Junhui Li, Ya-Jun Li, Xue Cheng Li, Ding-Biao Li, Xiying Li, Yansong Li, Weiyong Li, Xinyang Li, Cui Li, Xiaoyong Li, Y L Li, Xueyi Li, Jingxiang Li, Wenxue Li, Jianglin Li, Yingpu Li, Yan-Hua Li, Jing-Yao Li, Shawn Shun-Cheng Li, Xiao-Min Li, Wan Jie Li, Ya-Ting Li, Dongbiao Li, Keguo Li, Yuanfei Li, Longhui Li, Jing-Yi Li, Zhonghua Li, Chunyi Li, Peiyun Li, Qinglan Li, Yue-Ting Li, Da Li, YiPing Li, Demin Li, Haipeng Li, Chuan Li, Ze-An Li, Jianmin Li, Minhui Li, Yu Li, Yiwei Li, Xiangzhe Li, Minglun Li, Xue-Min Li, Kenneth Kai Wang Li, Chunlan Li, Chiyang Li, Hulun Li, Juan-Juan Li, Hua-Zhong Li, Jiaomei Li, Xiangyun Li, Jing Li, Yingshuo Li, Baixing Li, Dengke Li, Qingling Li, Rui-Han Li, Dong Li, Xiaoxia Li, Dezhi Li, Sheng-Jie Li, Ying-Qing Li, Xin-Jian Li, Guangxi Li, Yanhui Li, Sha-Sha Li, Mengxuan Li, Ziyu Li, Gang Li, Panyuan Li, Hong-Wen Li, Xiaojuan Li, Dongnan Li, Huaiyuan Li, Ji-Liang Li, Huaping Li, C H Li, Bohua Li, Pei-Ying Li, Shaobin Li, Ronald Li, Shilun Li, Shi-Hong Li, John Zhong Li, Xinyu Li, Lujiao Li, Song-Chao Li, Chenghong Li, Baohua Li, Nianfu Li, Jun-Cheng Li, Yimeng Li, Chunting Li, Chien-Feng Li, Mei-Zhen Li, Zhengjie Li, Liwei Li, Yan-Yan Li, Huijun Li, Chengyun Li, Lijun Li, Hening Li, Fengxia Li, Jialing Li, Xin Li, Ningyan Li, Zhenghui Li, Ailing Li, Chaochen Li, Tengyan Li, Xianlu Li, Jiaqi Li, Jiabei Li, Wenjing Li, Jingshu Li, Han-Bo Li, Zengyang Li, Chunyan Li, Runzhen Li, Xi-Hai Li, Xuezhong Li, MengGe Li, Pei-Lin Li, Wan-Xin Li, Ruobing Li, Ning Li, Meitao Li, Xia Li, Ziqiang Li, Wen-Xi Li, Shenghao Li, Hehua Li, Yucheng Li, Dujuan Li, Yuying Li, Shaofei Li, Shaoguang Li, Min-Rui Li, Shuqiang Li, Dan C Li, Huashun Li, Ganggang Li, Haoqi Li, Handong Li, Yan-Nan Li, Xianglong Li, Jing-Jing Li, Songhan Li, Conglin Li, Qingli Li, Miao Li, Chenyu Li, Ke Li, Zhen-Hua Li, Chuan-Yun Li, Gaoyuan Li, Youming Li, Qingrun Li, Dong-Yun Li, Shuangfei Li, Fengfeng Li, Qinggang Li, Huixia Li, Xingye Li, Xiangjun Li, Huiying Li, Xingyu Li, Zhaoping Li, Wenying Li, Honghui Li, Cheung Li, Xuelian Li, Zhenming Li, Changyan Li, Mulin Jun Li, Shangjia Li, Jingjing Li, Suhong Li, Xinping Li, Siyu Li, Guangzhen Li, Xiangyan Li, Shiyun Li, Xiaoyu Li, Yaobo Li, Xuewang Li, Mei Li, Manjiang Li, Wan Li, Xiao-Li Li, Xiaoya Li, Shan Li, Shitao Li, Zehan Li, Lijia Li, Huiliang Li, Chunqiong Li, Junjun Li, Hui-Long Li, Zhao-Cong Li, Zhi-Wei Li, Wenxi Li, Chang-hai Li, Yuqiu Li, Xue-Yan Li, Yuan-Yuan Li, Xiang-Jun Li, Chia Li, Y X Li, Yunyun Li, Zhen-Jia Li, Qiuxuan Li, De-Jun Li, Keqing Li, Junxian Li, Shuwen Li, Lingjun Li, Deheng Li, Si-Xing Li, Yaodong Li, Shigang Li, Gao-Fei Li, Minle Li, Le-Le Li, Ziwen Li, Yongqiu Li, Pu-Yu Li, Nan-Nan Li, Lan-Lan Li, Hongming Li, Shuang Li, Wanting Li, Gong-Hua Li, Zhengyu Li, Weiguang Li, Guoqing Li, Xiaomeng Li, Yuanze Li, Yunqi Li, Yuandong Li, Changcheng Li, Shiyue Li, Hanbo Li, Yinggao Li, Dingshan Li, Linlin Li, Jin-Wei Li, Cheng-Tian Li, Yaxi Li, Wei-Ming Li, Ming-Han Li, Wenchao Li, Guangyan Li, Zhaosha Li, Xuesong Li, Chun-Quan Li, Yongzhen Li, Tao Li, Xiankai Li, Yaxuan Li, Tian-wang Li, Yuchan Li, Jiaxi Li, Yalin Li, Pei-Zhi Li, Guanyu Li, Jinlan Li, Huizi Li, Jianping Li, Yun-Lin Li, Yadong Li, Sujing Li, Wenzhuo Li, Xuri Li, Mengqiu Li, Yun Li, Ling-Ling Li, Chengwen Li, Shu-Feng Li, Haojing Li, Zhiyu Li, Ziyang Li, Yaochen Li, Qian Li, Bohao Li, Wenyang Li, Wenming Li, Mingxuan Li, Bingsong Li, Anqi Li, Shuai Li, Xiaoju Li, Na Li, Huibo Li, Chuanfang Li, Pengsong Li, Ruotian Li, Chunya Li, En-Min Li, Zong-Xue Li, Yan Ning Li, Honglin Li, Min-jun Li, Jinhua Li, Qian-Qian Li, Yuanheng Li, Chunxiao Li, Shijun Li, Kuan Li, Baoguang Li, Jie-Shou Li, Zimeng Li, Mengmeng Li, W-B Li, Binkui Li, Yu-Sheng Li, Junjie Li, Xiaoqi Li, Xiucui Li, Haihua Li, Yu-Lin Li, Tsai-Kun Li, Shujing Li, Mengyun Li, Mingna Li, Lanlan Li, Moyi Li, Xiyun Li, Ya-Pei Li, Zhongjie Li, Zhenbei Li, Shuangshuang Li, Hongwei Li, Ding-Jian Li, Xiao-Qiang Li, Danni Li, Min Li, Pengyang Li, Kun-Xin Li, Xiangpan Li, Zesong Li, Mingfei Li, Shuwei Li, Mingdan Li, Xihe Li, Jianfeng Li, Dexiong Li, Rongsong Li, Yinxiong Li, Hong-Yu Li, Weijian Li, Changhui Li, Dechao Li, Wenxia Li, Ziru Li, Juxue Li, Man Li, Huayin Li, Xiao-yu Li, Jianyi Li, Guowei Li, Xingya Li, Gongda Li, Yajun Li, Wei-Ping Li, Nanjun Li, P H Li, Ranran Li, Suping Li, Jason Li, Monica M Li, Xianlun Li, Qi Li, Xiaoli Li, Xionghui Li, Fei Li, Hongmei Li, Xu-Wei Li, Mengsen Li, Quanpeng Li, Yajiao Li, Qilan Li, Qiuhong Li, Zongyun Li, Xiao-Yun Li, Cheng-Lin Li, Yousheng Li, Wen-Ting Li, Guoping Li, A Li, Simin Li, Weiguo Li, Xue-Nan Li, Xiaoying Li, Shengsheng Li, Hong Li, Yuqi Li, Zihua Li, Qing Li, Jiaping Li, Weiyang Li, Feng Li, Peihong Li, Jin-Mei Li, Lisha Li, Cuicui Li, Kaibo Li, Hanbing Li, Meng-Hua Li, J T Li, Xiangwei Li, Baiqiang Li, Ziliang Li, Donghe Li, Zheng Li, Congfa Li, Wenrui Li, Yong Li, Xiuling Li, Jingqi Li, Zhiyong Li, Xiao-Kang Li, Hanqi Li, Yangyang Li, Dongfang Li, Zhuorong Li, X-H Li, Dong Sheng Li, Lan-Juan Li, Xianrui Li, Zhigao Li, Chenlin Li, Zihui Li, Guoli Li, Huanqiu Li, Zhan Li, Weisong Li, Xinglong Li, Xiaozhen Li, Zhiyang Li, Cunxi Li, Ying Li, Jianlin Li, Yanshu Li, Guiying Li, Jinku Li, Cuiling Li, Zhisheng Li, Changgui Li, Xuekun Li, Yuguang Li, Wenke Li, Jiayi Li, Suwen Li, Peihua Li, Chang-Ping Li, Guangda Li, Jieming Li, Chunhui Li, Tongyao Li, Peiyu Li, Linfeng Li, Yuzhe Li, Qifang Li, Chang-Yan Li, Xiaolin Li, Duanxiang Li, Vivian Li, Justin Li, Meiting Li, Xue-Er Li, Hongchang Li, Youwei Li, Ronggui Li, Xingwang Li, Tiange Li, Yongjia Li, Dacheng Li, Xinmin Li, Luquan Li, Guoxing Li, Jianyong Li, Zongchao Li, Jia Li, Haimin Li, Sheng-Qing Li, Lingjie Li, Yiwen Li, Baoqi Li, Leyao Li, Xiao-Qin Li, Jiajing Li, Yanlin Li, Liao-Yuan Li, Yongkai Li, Hangwen Li, Hengguo Li, An-Qi Li, Xuehua Li, AnHai Li, Chenli Li, Zhengrui Li, Rumei Li, Yan-Yu Li, Lipeng Li, Qinqin Li, Qinghua Li, Leilei Li, Lianyong Li, Zhou Li, Q Li, Bizhi Li, Cheng-Wei Li, Wenwen Li, Jian'an Li, Guangqiang Li, Sichong Li, Wenyi Li, Qing-Min Li, Meiyan Li, Yun-Da Li, Jian-Qiang Li, Yingrui Li, Chenfeng Li, Shen Li, Ziqi Li, Yunfeng Li, Shufen Li, Yueqi Li, Xiao-Guang Li, Jiali Li, Zhencheng Li, Qiufeng Li, Pinghua Li, Xu Li, Zhenli Li, Yunxiao Li, Rosa J W Li, Hsin-Yun Li, XiaoQiu Li, Zhankui Li, Zhi Li, Zhijie Li, Huimin Li, Ruifang Li, Xiao-xu Li, Man-Xiang Li, Cong Li, Chengbin Li, Yuping Li, G Li, Zhi-Yong Li, Yukun Li, Xiong Bing Li, Wen Lan Li, Qingjie Li, Han Li, Yutang Li, Hankun Li, Hongling Li, Zhifan Li, Yan-Guang Li, Ji-Min Li, Peipei Li, Tian-Yi Li, Zhihao Li, Yao Li, Zheyun Li, Zhonglin Li, Lin Li, Jinfang Li, Chenjie Li, Yanming Li, S L Li, Ben-Shang Li, Hong-Lan Li, Xionghao Li, Shunqing Li, Ming-Kai Li, Lan Li, Yanwei Li, Chien-Te Li, Wenyan Li, Xiaoheng Li, Zeyuan Li, Hongqin Li, Zhenhao Li, Jonathan Z Li, Yong-Liang Li, M Li, Jiehan Li, Hongguo Li, Chenxin Li, Yongsen Li, Qingyun Li, Pengyu Li, Ai-Qin Li, Zichao Li, Cien Li, Qingyu Li, Xijing Li, Jingshang Li, Xingyuan Li, Dehua Li, Yanjiao Li, Jia-Huan Li, Guoxi Li, Xudong Li, Xingfang Li, Jisheng Li, Rongyao Li, Ru Li, Jiangya Li, Yiche Li, Yilang Li, Yunshen Li, Jingchun Li, Hexin Li, H J Li, Yanping Li, Qing-Wei Li, Qiang Li, Hsiao-Hui Li, L I Li, Hongzheng Li, Laiqing Li, Ningyang Li, Zhongxia Li, Guangquan Li, Shun Li, Hui-Jun Li, Xuefei Li, Guojun Li, Hung Li, Senlin Li, Jinping Li, Sainan Li, Jinghui Li, Zulong Li, Chengsi Li, P Li, Fulun Li, Yonghao Li, Mingli Li, Yehong Li, Pei Li, Quanshun Li, Yongping Li, Liguo Li, Weimin Li, Mingxia Li, Xue-Hua Li, M V Li, Gan Li, Shichao Li, Dapei Li, Zejian Li, Lihong Li, Haixia Li, Jingmei Li, Ao Li, Yitong Li, Siwen Li, Yanlong Li, Zhao Li, Kui Li, Yunxu Li, Xuanfei Li, Zilin Li, Mingqiang Li, Xiaojiao Li, Yinzhen Li, Yunsheng Li, Li-Min Li, Xiangqi Li, Jia-Peng Li, Wenqi Li, Haibo Li, Xiao-Jun Li, Yan-Hong Li, Shi Li, Xueling Li, Conghui Li, Xiaoxiong Li, Wanni Li, Chitao Li, Haiyang Li, Xiaobai Li, Pingping Li, Mingquan Li, Suran Li, Yuanfang Li, Yingqin Li, Qiner Li, Jiafang Li, Shanhang Li, Han-Bing Li, Zongzhe Li, Yikang Li, Si-Yuan Li, Hongmin Li, Caihong Li, Yajing Li, Benyi Li, Yuquan Li, Hongzhi Li, Chengxin Li, Xiaojiaoyang Li, Xinxin Li, Jian-Shuang Li, Yubin Li, Dazhi Li, Chenglan Li, Yuhong Li, Fengqiao Li, Di Li, Yanbing Li, Jufang Li, Zecai Li, Qipei Li, Xiaoning Li, Xiyue Li, Minghua Li, Tianchang Li, Zhuoran Li, Hongru Li, Shiqi Li, Mei-Ya Li, Wuyan Li, Yi-Ling Li, Yingjian Li, Zhirong Li, Wang Li, Mingyang Li, Weijun Li, Boyang Li, Cai Li, Jingcheng Li, Ivan Li, Mengshi Li, Manxia Li, Ya Li, Dan-Ni Li, Wen-Chao Li, Sunan Li, Zhencong Li, Lai K Li, Jiong Li, Daiyue Li, Bingong Li, Chunxue Li, Yunlong Li, Jianshuang Li, Juanling Li, Xinbin Li, Xue-jing Li, Yuling Li, Yetian Li, Xianlin Li, Chuangpeng Li, Mingrui Li, Yanjun Li, Jiequn Li, Zhongding Li, Jiangui Li, Zhengyang Li, Cyril Li, Xinghui Li, Yuefei Li, Xinyan Li, Xiaoyun Li, Yushan Li, Ping'an Li, Weiping Li, Huan Li, Changjiang Li, Chengping Li, He-Zhen Li, G-P Li, Yinliang Li, Wen Li, Weihai Li, Yu-Kun Li, Jiangan Li, Zhaojin Li, Bingxin Li, Wenjuan Li, Chia-Yang Li, Wenyu Li, Hairong Li, Su Li, Mei-Lan Li, Wenjun Li, Jiaxin Li, Chenguang Li, Ming D Li, Ruyue Li, Xiaolian Li, Ya-Ge Li, Yinyan Li, Guangli Li, Rujia Li, Qijun Li, Lixia Li, Yunrui Li, Yuhuang Li, Shanshan Li, Wan-Shan Li, Jing-gao Li, Yiyang Li, Fengxiang Li, Nana Li, Jingui Li, Huamao Li, Xiankun Li, Jingke Li, Tianyao Li, Xiaowei Li, Junming Li, Hai-Yun Li, Zhongxian Li, H-J Li, Zhixiong Li, Lingyan Li, Xuhang Li, Chen-Lu Li, Jialun Li, Xinjian Li, Zilu Li, Sheng-Fu Li, Zezhi Li, Xue-Fei Li, Yudong Li, Hongjiang Li, Jingyun Li, Binghua Li, Hanjun Li, Qihua Li, Jin-Qiu Li, Jiaxuan Li, Guangjin Li, Xutong Li, Ranwei Li, Kai Li, Wei-Li Li, Keanning Li, Ling Li, Peiqin Li, Xiaodong Li, Nanxing Li, Qihang Li, Baoguo Li, Jianrong Li, Zhehui Li, Chenghao Li, Weike Li, Chuanbao Li, Zhixuan Li, Chuzhong Li, M D Li, Yuan-Tao Li, Kening Li, Guilan Li, Wanshi Li, Ling-Zhi Li, Hengtong Li, Yifan Li, Ya-Li Li, Songyun Li, Xiaoran Li, Bolun Li, Linchuan Li, Jiachen Li, Haibin Li, Huangbao Li, Guo-Chun Li, Xinli Li, S Li, Wenqing Li, Wenhua Li, Caiyun Li, Xinrui Li, Hanbin Li, Wanwan Li, Jia Li Li, Wan-Hong Li, Mingke Li, Huanhuan Li, Xiaoyuan Li, Zongfang Li, Yang Li, BoWen Li, Duoyun Li, Yimei Li, Zhi-qiang Li, Yi-Ting Li, Jiangxia Li, Yujie Li, Zhiping Li, Yan-Li Li, Haiming Li, Gaijie Li, Yuemei Li, Xuefeng Li, Xiao-Hong Li, Mengjuan Li, Yinglin Li, Yaofu Li, Ren-Ke Li, Yi Li, Baosheng Li, Mian Li, Yujun Li, Lixi Li, Jin-Xiu Li, Jiwen Li, Zhouhua Li, Qingqin S Li, Honglei Li, Guojin Li, Xin-Yue Li, Dingchen Li, Xiaoling Li, Meng-Jun Li, Peining Li, Congjiao Li, Huilin Li, Songtao Li, Fusheng Li, Dai Li, Meiyue Li, Kechun Li, Keshen Li, Yuxin Li, Shaoliang Li, Shu-Xin Li, Hong-Zheng Li, Tianye Li, Qun Li, Zhen Li, Mengling Li, Jia-Da Li, Baoqing Li, Pu Li, Xingli Li, Bingkun Li, Nien-Chi Li, Tiewei Li, Daniel Tian Li, Rong-Bing Li, Wei-Yang Li, Rong Li, Mingkun Li, Binxing Li, Zixiao Li, Guixin Li, Quanzhang Li, Da-wei Li, Xiumei Li, Melody M H Li, Peibo Li, Huanjun Li, Chung-Hao Li, Liuzheng Li, Zhanjun Li, Yifei Li, Tianming Li, Chang-Sheng Li, Tianyou Li, Jipeng Li, Longxuan Li, Shi-Guang Li, Wenxiu Li, Zhuang Li, Yu-Hao Li, Shilin Li, Shili Li, Meiqing Li, Hengyu Li, Yinhao Li, Junying Li, Mufan Li, Chun-Lai Li, Shiya Li, Xiao-Jiao Li, Li Li, Hanxue Li, Lulu Li, L P Li, Xiaoqin Li, Chunmei Li, Mingjun Li, Yuanhua Li, Qiaolian Li, Ji-Cheng Li, Haolong Li, Xuanzheng Li, Peng-li Li, Quan Li, Xue-Ying Li, Yongzhe Li, Tianyi Li, Qingfeng Li, Nanlong Li, Ping Li, Fangzhou Li, Nien-Chen Li, Yuanchuang Li, Haiying Li, Yunting Li, Hong-Yan Li, Shengbiao Li, Yue-Rui Li, Ruidong Li, Y M Li, Sijie Li, Meilan Li, D C Li, Andrew C Li, Jianye Li, Qiuyan Li, Tingguang Li, Xiangyang Li, Chunjie Li, Tianfeng Li, Anna Fen-Yau Li, Minghui Li, Jiangfeng Li, Jie-Pin Li, Kaiyi Li, Junyi Li, Dongtao Li, Fengyuan Li, Chenxi Li, Zuo-Lin Li, Zhengwei Li, Yan-Chun Li, Suiyan Li, Qiaoqiao Li, Xiaotian Li, Zhenguang Li, Jia-Ru Li, Pei-Qin Li, Chun-Xiao Li, Shu-Hong Li, Shuyue Li, Quan-Zhong Li, Tongzheng Li, Fangyan Li, Duo Li, Ren Li, Hongye Li, Lanfang Li, Mingwei Li, Wenxin Li, W J Li, Zhijia Li, Jingtong Li, Lucy Li, Zhengpeng Li, Xiayu Li, Baolin Li, Cuilan Li, Yuting Li, Xiaobo Li, Meijia Li, Shujiao Li, Kun-Ping Li, Weirong Li, Weihua Li, Runzhao Li, Xiang-Dong Li, Yanxin Li, Xiufeng Li, Yingjun Li, Xiaohuan Li, Ying-Qin Li, Fan Li, Jun Z Li, Yiheng Li, Taiwen Li, Xiaorong Li, Haifeng Li, Liping Li, Rena Li, Jiangtao Li, Yu-Jui Li, Rui-Jún Eveline Li, Xuanxuan Li, Bing-Mei Li, Yunman Li, Shuhua Li, Chunying Li, Leipeng Li, Weiheng Li, Baizhou Li, Han-Ru Li, Sheng Li, Yaqiang Li, Guoyin Li, Qiwei Li, Chengjun Li, Jianxiong Li, Ji Li, Huaying Li, Tuojian Li, Yixin Li, Ziyue Li, Juntong Li, Xiang Li, Chaonan Li, Yu-Chia Li, Heying Li, Shaomin Li, Yuxuan Li, Xuan-Ling Li, Bingshan Li, Jiahao Li, Shibao Li, Ruijin Li, Kunlong Li, Xiaofeng Li, Zhaolun Li, Litao Li, Ruyi Li, Wanxin Li, Jinsong Li, Ying-Lan Li, Yulin Li, Shaojian Li, Mohan Li, Yan-Xue Li, Enhong Li, Xiangnan Li, Yong-Jun Li, Hang Li, Ziming Li, Jing-Ming Li, Yuanchang Li, Xiao-Lin Li, Yicun Li, Zhao-Yang Li, K-L Li, Xinjia Li, Bin Li, Jianhai Li, Peiwu Li, Youran Li, Changyu Li, Ming Zhou Li, Z Li, Xinmei Li, Wulan Li, Haoxian Li, Xiaozhao Li, Da-Lei Li, Jinming Li, Huihui Li, Kailong Li, Qiankun Li, Shengxu Li, Xiuli Li, Yulong Li, Ru-Hao Li, Zhi-Peng Li, Lanzhou Li, Tingsong Li, Binjun Li, Chen Li, Yawei Li, Chao Bo Li, Donghua Li, Siming Li, Fengli Li, Song Li, Hsin-Hua Li, You Li, Dongfeng Li, Zhen-Yuan Li, Xuelin Li, Xueyang Li, Bao Li, Yin Li, Cai-Hong Li, Dejun Li, Yufeng Li, Miaoxin Li, Hu Li, Bei Li, W H Li, Sha Li, Ya-Qiang Li, Xiushen Li, Jinlin Li, Xiaoqing Li, Shuaicheng Li, Xuebiao Li, Yingyi Li, Maolin Li, Jiyang Li, Zhongxuan Li, Linting Li, Zhong-Xin Li, Enhao Li, Shengliang Li, Hujie Li, Yue-Ming Li, Zhaohan Li, Alexander Li, Wen-juan Li, Pilong Li, Yun-Peng Li, C X Li, Huanan Li, Miao X Li, KeZhong Li, Linying Li, Chu-Qiao Li, Fa-Hong Li, Changzheng Li, Yaokun Li, Zhi-Gang Li, Yufan Li, Liangqian Li, Guanghui Li, Xiongfeng Li, Side Li, Timmy Li, Jiezhen Li, Qiuya Li, Haitao Li, Yufen Li, Qin Li, Annie Li, Wenge Li, Xueren Li, Chun-Mei Li, Meng-Yao Li, Chung-I Li, Zhi-Bin Li, Junping Li, Xiao Li, PeiQi Li, Xiaobing Li, Liangdong Li, Yan Li, Shengchao A Li, Pan Li, Huiqiong Li, Guigang Li, Lucia M Li, Chunzhu Li, Chengquan Li, Zexu Li, Zhilei Li, Tiantian Li, Wenyong Li, Desen Li, Tianjun Li, Zihao Li, Fadi Li, Huawei Li, Yu-quan Li, Jihua Li, Jingping Li, Zhiquan Li, Zeyu Li, Zongdi Li, Ming V Li, Aowen Li, L K Li, Aimin Li, Tiehua Li, Guohong Li, Botao Li, L-Y Li, Xiuqi Li, Zhenhua Li, Zhengda Li, Haotong Li, Luhan Li, Yuancong Li, Tian Li, Yuxiu Li, Beibei Li, Changhong Li, Yvonne Li, Zhichao Li, Jiayuan Li, Yige Li, Siguang Li, Chengqian Li, Weiye Li, Dong-fei Li, Xiangchun Li, Hailong Li, Kun-Peng Li, Haijun Li, Si Li, Ji-Feng Li, Wanqian Li, Zijing Li, Wentao Li, Yuchuan Li, Xuhong Li, Hongyun Li, Zhonggen Li, Xiong Li, Penghui Li, Huiting Li, Xiaolong Li, Linqing Li, Jiawei Li, Defa Li, X L Li, Yuyan Li, Kawah Li, Shupeng Li, Zhenfei Li, Zhuo Li, Han-Wei Li, Weina Li, Xiao-Hui Li, Rui-Fang Li, Jianzhong Li, Bing Li, Huihuang Li, Yunmin Li, Yanying Li, Gui Lin Li, Chenrui Li, Dengfeng Li, N Li, Xiaotong Li, Chensheng Li, Ming-Qing Li, Yongxue Li, Bao-Shan Li, Zhimei Li, Jiao Li, Jingming Li, Jinxia Li, De-Tao Li, Shu Li, Julia Li, Huilan Li, Xin-Ya Li, Chunsheng Li, Chengjian Li, Ying-na Li, Guihua Li, Zhiyuan Li, Supeng Li, Yiju Li, Yuanhe Li, Guangxiao Li, Xueqin Li, Peixin Li, Feng-Feng Li, Zu-Ling Li, Yunjiu Li, Dayong Li, Zonghong Li, Lingjiang Li, Yuhan Li, Fuyuan Li, H-F Li, Chunxia Li, Zhen-Li Li, Zhengying Li, Zhaoshui Li, Yali Li, Yu-Hui Li, Chuang Li, Jiajun Li, Can Li, Zhe Li, Stephen Li, Shuangding Li, Mangmang Li, Kaiyuan Li, Xiaopeng Li, Anan Li, Luying Li, Jiajv Li, Xiaoquan Li, Yanxi Li, Yongjing Li, Huayao Li, Jiqing Li, Huixue Li, Boxuan Li, Yongqi Li, Qingyuan Li, Fengqi Li, Yuqing Li, Zhigang Li, Guiyang Li, Guo-Qiang Li, Yanbo Li, Sanqiang Li, Hongyu Li, Guangping Li, Jinxin Li, Xinrong Li, Yayu Li, Huaixing Li, Minyue Li, Hong-Mei Li, Jutang Li, Mengxia Li, Yongxiang Li, Qilong Li, Songlin Li, Dijie Li, Yizhe Li, Yan Bing Li, Jiani Li, Lianjian Li, Yiliang Li, Xinpeng Li, Hongxing Li, Wanyi Li, Mi Li, Guo Li, Jingxia Li, Xiu-Ling Li, Fuhai Li, Ruijia Li, Yumiao Li, Jiexi Li, Kecheng Li, Junxu Li, Junya Li, Jiang Li, Shengxian Li, Qingyang Li, Yuxi Li, Chenxuan Li, Xiao-Dong Li, Xinghuan Li, Zhenlu Li, Xiaolei Li, Huilong Li, Xiao-Gang Li, Zhenhui Li, Chunjun Li, Shu-Fen Li, Yinghua Li, Yanjie Li, Chaoying Li, Juanjuan Li, Qiu Li, Kunlun Li, Shiquan Li, Xiangdong Li, Zhenjia Li, Jifang Li, Zhizhong Li, Ding Yang Li, Chenlong Li, Shujin Li, Weining Li, Wu-Jun Li, Yumao Li, Bin-Kui Li, Honglian Li, Ya-Zhou Li, Hongyi Li, Fu-Rong Li, Honghua Li, Lanjuan Li, Man-Zhi Li, Xiancheng Li, Yanmei Li, Zhihua Li, Minqi Li, Saijuan Li, Danxi Li, Mimi Li, Yingjie Li, Yuan-Hai Li, Lujie Li, Minghao Li, Meifen Li, Yifeng Li, Huanqing Li, Yuhang Li, Jianhua Li, Chanjuan Li, Lingyi Li, Yanchuan Li, Bai-Qiang Li, Chunmiao Li, Jiong-Ming Li, Yongqiang Li, Linsheng Li, Mingyao Li, Ze Li, R H L Li, Guisen Li, Dongyang Li, Jinglin Li, Honglong Li, Mingfang Li, Hanmei Li, Chenmeng Li, Shiyang Li, Jianing Li, Xinsheng Li, Jin-Jiang Li, Zhi-Xing Li, Chang Li, Jiwei Li, Weifeng Li, Wenhui Li, Sichen Li, Qingsheng Li, Liangji Li, Lixiang Li, Jin-Liang Li, Xiaoqiong Li, You Ran Li, Yixiao Li, Kathy H Li, Yuhua Li, Deqiang Li, Y Li, Mingyue Li, Zipeng Li, Caixia Li, Hongli Li, Yanfeng Li, Yaqin Li, Yu-He Li, Shasha Li, S-C Li, Xi Li, Siyi Li, Minmin Li, Manna Li, Dawei Li, Xun Li, Ming-Jiang Li, Sitao Li, Tinghua Li, Zhenfen Li, Shuo Li, Si-Ying Li, Xinyi Li, Jenny J Li, Xue-zhi Li, Xiaonan Li, Zhenyu Li, Ting Li, Xiang-Yu Li, Duan Li, Lei Li, Hongde Li, Fengqing Li, Yanchang Li, Xunjia Li, Ruixia Li, Nanzhen Li, Hongxue Li, Bingjie Li, Xiaojing Li, Xinlin Li, Yu-Ying Li, Wenli Li, Mengze Li, Kaiwei Li, Huangyuan Li, Lili Li, Junxin Li, Wei-Jun Li, Guoyan Li, Fei-Lin Li, Nuomin Li, Yanyan Li, Shulin Li, Shanglai Li, Taibo Li, Yue Li, Junqin Li, JunBo Li, Jun-Ru Li, Xueying Li, Zhongcai Li, Zhaobing Li, Linxin Li, Jen-Ming Li, Chen-Chen Li, Hongquan Li, Chuan F Li, Yanxiang Li, Yi-Wen Li, Shihong Li, Rulin Li, Huifeng Li, Lijuan Li, Yuanhong Li, Shengbin Li, Jingyu Li, Xuewei Li, Long Li, Min-Dian Li, Wenjia Li, Xiatian Li, Yangxue Li, Chengnan Li, Chuanyin Li, Yiqiang Li, Zhenzhou Li, Xiawei Li, Binglan Li, Yutong Li, Yingnan Li, Ge Li, Xinzhong Li, Chenyao Li, Jun-Yan Li, Boru Li, Ruixue Li, Zemin Li, Jixi Li, Chris Li, Jicheng Li, Chuanning Li, Jiafei Li, Yingying Li, Gaizhi Li, Chien-Hsiu Li, Xiangcheng Li, Siqi Li, Chunxing Li, Qiao-Xin Li, Huang Li, Shu-Fang Li, Qiusheng Li, Weiqin Li, Xinming Li, Yongjun Li, Mengyang Li, Guo-Jian Li, Chenglong Li, Nan Li, Yipeng Li, Mingxing Li, Xin-Yu Li, Chunyu Li, Jinwei Li, Xuhua Li, Yu-Xiang Li, Long Shan Li, Yanze Li, Xiao-Feng Li, W Li, Fengjuan Li, Hainan Li, Yutian Li, Xiliang Li, Shuangmei Li, Ying-Bo Li, Duanbin Li, Maogui Li, Dan Li, Sumei Li, Peilong Li, Kang Li, Yinghao Li, Lirong Li, Wenhong Li, Audrey Li, Yijian Li, Guang Y Li, Xianyong Li, Shilan Li, Guang-Li Li, Bang-Yan Li, Enxiao Li, Jianrui Li, Guohua Li, Kezhen Li, Xingxing Li, Ellen Li, Yijie Li, Suwei Li, Shuyu D Li, Ruiwen Li, Jiandong Li, Fangyong Li, Binru Li, Yuchao Li, Hanlu Li, Jianang Li, Xue-Peng Li, Sheng-Tien Li, Shihao Li, Yazhou Li, Jun-Ling Li, Caesar Z Li, Lang Li, Feifei Li, Kejuan Li, Qinghong Li, Qiqiong Li, Xinxiu Li, Chongyi Li, Yi-Ying Li, Shaodan Li, Yongzheng Li, Da-Hong Li, Xiao-mei Li, Jiejie Li, Ruihuan Li, Yaoyao Li, Yueguo Li, Mo Li, Ming-Hao Li, Hongsen Li, Menghua Li, Ka Li, Kaixin Li, Fuping Li, Jianbo Li, Xing-Wang Li, Chong Li, Fugen Li, Yuwei Li, Xiaochen Li, Zizhuo Li, Xiaoxiao Li, Le-Ying Li, Pengcui Li, Bing-Heng Li, Xiaoman Li, Xiaohong Li, Yuan Hao Li, Jianchun Li, Wenxiang Li, Zhaoliang Li, Guo-Ping Li, Zhifei Li, Jinhui Li, Yuanyou Li, Chongyang Li, Wanyan Li, Yumin Li, Longyu Li, X B Li, Jianguo Li, En Li, Ximei Li, Shaoyong Li, Kai-Wen Li, Guandu Li, Yixue Li, Junfeng Li, Xin-Chang Li, Yue-Ying Li, Kongdong Li, Lian Li, Xinmiao Li, Chenyang Li, Jiacheng Li, Xiaohua Li, Zhuangzhuang Li, Xiaohui Li, Cang Li, Xuepeng Li, Mingjiang Li, Zongyu Li, Shujie Li, Yanbin Li, Shiliang Li, Qinrui Li, Yiming Li, Xiao-Tong Li, Tie Li, Wei-Bo Li, Xiaoyi Li, Liyan Li, Xinke Li, Xiaokun Li, Ming-Wei Li, Minzhe Li, Wenfeng Li, Karen Li, X Li, Meifang Li, Yanjing Li, Maosheng Li, Ju-Rong Li, Shibo Li, Jin Li, Li-Na Li, Hui Li, Fangqi Li, Xiaoguang Li, Xian Li, Danjie Li, Vivian S W Li, Ranchang Li, Defu Li, Amy Li, Haoyu Li, Xiaoyao Li, M-J Li, Jiao-Jiao Li, Zhu Li, Rongling Li, Tong-Ruei Li, Ben Li, Yingxia Li, Yonghe Li, Xinwei Li, Yu-I Li, Shunhua Li, Mingxi Li, Qionghua Li, Guo-Li Li, Xingchen Li, Tianjiao Li, Gui-Rong Li, Yunpeng Li, Qiong Li, Songyu Li, Shi-Fang Li, Shude Li, Zhibin Li, Yaxiong Li, Qing-Fang Li, Shengwen Li, Gui-Bo Li, Xueer Li, Zihai Li, Yue-Jia Li, Haihong Li, Peifen Li, Mingzhou Li, Taixu Li, Jiejing Li, Meng-Miao Li, Meiying Li, Chunlian Li, Meng Li, Cun Li, T Li, Yinghui Li, Feilong Li, Sin-Lun Li, Weiling Li, Mengfan Li, Jie Li, Shiyan Li, Lianbing Li, Yanchun Li, Xuze Li, Jialin Li, Wenjian Li, He Li, Bichun Li, Hanqin Li, Guoge Li, Wen-Wen Li, Keying Li, Minze Li, Xingcheng Li, Wanshun Li, Congxin Li, Xiangrui Li, Caolong Li, Michelle Li, Chaojie Li, J Li, Zhi-Jian Li, Jianwei Li, Jiexin Li, Hongyan Li, Zhen-Xi Li, Guangdi Li, Xiaxia Li, Nien Li, Yuefeng Li, Peiyuan Li, Tiansen Li, Chi-Yuan Li, Xiangfei Li, Xue Li, Fen Li, Jieshou Li, Roger Li, Mengqing Li, Menglu Li, Huiqing Li, Yantao Li, Ruolin Li, Yongle Li, Haying Li, Shao-Dan Li, Muzi Li, Gen Li, Dong-Ling Li, Chenwen Li, Le Li, Yong-Jian Li, Si-Wei Li, Manru Li, Yingxi Li, Caili Li, Yuqian Li, Wei-Dong Li, Guannan Li, Ya-Feng Li, Wenlong Li, Yuna Li, Shengli Li, Shugang Li, Xuan Li, Yongze Li, Yongxin Li, Lu Li, Zhuo-Rong Li, Qinglin Li, Bingbing Li, Runzhi Li, Qi-Jing Li, Zhenyan Li, Ji Xia Li, Yu-Ye Li, Meizi Li, Yuezheng Li, Zhengnan Li, Jianglong Li, Xiaozheng Li, Huili Li, Hongzhe K Li, Xiao-Qiu Li, Jiejia Li, Yi-Yang Li, Zhihui Li, Fujun Li, Ni Li, Luxuan Li, Qiang-Ming Li, Yakui Li, Huafu Li, Xinye Li, Chunliang Li, Ruiyang Li, Chun Li, Jianan Li, Wenfang Li, Xiangling Li, Sung-Chou Li, Lianhong Li, Cheng Li, Tiegang Li, Zhong Li, Shuang-Ling Li, Xiao-Long Li, Xiaofei Li, Hung-Yuan Li, Zhang Li, Jianxin Li, H Li, Dongliang Li, Chenxiao Li, Hongjia Li, Xiao-Jing Li, Y H Li, Jian Li, Daoyuan Li, Baichuan Li, Zhenzhe Li, Jian-Mei Li, Kaimi Li, Peiran Li, Qiao Li, Yi-Yun Li, Xiao-Cheng Li, Yike Li, Yihan Li, Junsheng Li, Jiayu Li, Wen-Ya Li, Rongxia Li, Yunlun Li, Guoqin Li, Huiqin Li, Chunlin Li, Jisen Li, Peng Peng Li, Kenli Li, Guanglu Li, Xiushi Li, Dongmin Li, Jian-Jun Li, Fengyi Li, Yanling Li, Juanni Li, C Li, You-Mei Li, Beixu Li, Guiyuan Li, Suk-Yee Li, Shengjie Li, Yuanyuan Li, Xiaona Li, Shanyi Li, Chih-Chi Li, Hongbo Li, Xinhui Li, Jun Li, Mingzhe Li, Hongjuan Li, Senmao Li, Mingjie Li, Ling-Jie Li, Hong-Chun Li, Yaying Li, Liqun Li, Changxian Li, Chunqing Li, Yanni Li, Yongsheng Li, Xiujuan Li, Huifang Li, Lingling Li, Xinhua Li, Minerva X Li, Alexander H Li, Wendeng Li, Ding Li, Ming-Yang Li, Shengze Li, Linyan Li, Hewei Li, Da-Jin Li, Xiao-kun Li, Yuanhao Li, Ji-Lin Li, Congcong Li, Juan Li, Xiaobin Li, Shaoqi Li, Yuehua Li, Jinfeng Li, Shiheng Li, Hsiao-Fen Li, Mengjiao Li, Tianxiang Li, Meng-Meng Li, Liangkui Li, Tian-chang Li, Yahui Li, Wenlei Li, Xi-Xi Li, Haiyan Li, Xujun Li, Chi-Ming Li, Yi-Ning Li, Dandan Li, Yunan Li, Sherly X Li, Jiazhou Li, Zhijun Li, Zechuan Li, Wanling Li, Zhiwei Li, Xueshan Li, Jiangbo Li, Xiaohan Li, Huijie Li, Zhongwen Li, W W Li, Yalan Li, Xuejun Li, Shunwang Li, Yaqing Li, Chao Li, Yaqiao Li, Bingsheng Li, Jianfang Li, Shubo Li, Qi-Fu Li, Zi-Zhan Li, Haoran Li, Xiaoliang Li, Xinyuan Li, Maoquan Li, Chumei Li, Shijie Li, Zhanquan Li, Wenguo Li, Fangyuan Li, Xiaochun Li, Rui Li, Xuemin Li, Shanpeng Li, Wei-Na Li, Dong-Run Li, Yunxi Li, Xuyi Li, Yunchu Li, Zhengyao Li, Jinghao Li, Y-Y Li, Xiaofang Li, Tuoping Li, Pengyun Li, Lin-Feng Li, Ziqing Li, Shuangxiu Li, Yongjin Li, Chenhao Li, Weizu Li, Deming Li, Jiuyi Li, Chun-Xu Li, Luyao Li, Desheng Li, Long-Yan Li, Fuyu Li, Lingzhi Li, Xiao-Sa Li, Kunlin Li, Shu-Qi Li, Zehua Li, Mengyuan Li, Congye Li, Wensheng Li, Dehai Li, Qingshang Li, Jiannan Li, Guanbin Li, Zhiyi Li, Xing Li, Zhaoyong Li, SuYun Li, Shiyi Li, Suchun Li, Yanan Li, Jiayan Li, YueQiang Li, Xiangping Li, H-H Li, Jinman Li, Dongdong Li, Hao Li, Liliang Li, Mengxi Li, Keyuan Li, Shaojing Li, S S Li, Tong Li, Yilong Li, Lihua Li, Xue-Lian Li, Yansen Li, Hai Li, Zhi-Yuan Li, Jingfeng Li, Yanli Li, Yuan-Jing Li, Kaibin Li, Xiaohu Li, Wenjie Li, Ruikai Li, Qiyong Li, Ruixi Li, Zhonglian Li, Dalin Li, Kun Li, Qizhai Li, Pengju Li, Peifeng Li, Ai-Jun Li, Yueting Li, YaJie Li, Zijian Li, Yanqing Li, Jixuan Li, Zhandong Li, Xuejie Li, Gaizhen Li, Liang Li, Huafang Li, Nianyu Li, Chenlu Li, X-L Li, Shawn S C Li, Cuiguang Li, Dongye Li, F Li, Chunhong Li, Yuan Li, Kunpeng Li, Zhenghao Li, Chun-Bo Li, Zhantao Li, Xinle Li, Wuguo Li, Bing-Hui Li, Honggang Li, Jingyong Li, Shikang Li, Shi-Ying Li, Ming Xing Li, Ming-Xing Li, Marilyn Li, Bei-Bei Li, Hong-Lian Li, Shishi Li, Haitong Li, Yuli Li, Ruibing Li, Qingfang Li, Qibing Li, Wende Li, Heng Li, Xiao-Na Li, Xidan Li, Yixing Li, Chengcheng Li, Yu-Jin Li, Baoting Li, Ka Wan Li, Huiyou Li, Binbin Li, Xinyao Li, Gui-xing Li, Niu Li, Shunle Li, Siyue Li, Diyan Li, Mengyao Li, Yixuan Li, Shan-Shan Li, Zhuanjian Li, Gerard Li, Yuyun Li, Zhiqiong Li, Zonglin Li, Pik Yi Li, Jingxin Li, Defeng Li, Zu-guo Li, Xin-Zhu Li, Jia-Xin Li, Kuiliang Li, Pindong Li, Hualian Li, Junhong Li, Youchen Li, W Y Li, Yi-Heng Li, Runbing Li, Yanmin Li, Jingyi Li, Yuxiang Li, Hao-Fei Li, Yining Li, Xiurong Li, Haiyu Li, Huijuan Li, Yunze Li, Xu-Zhao Li, Yanzhong Li, Kainan Li, Guohui Li, Xiaoyan Li, Xu-Bo Li, Yue-Chun Li, Jiahui Li, Huiping Li, Kangyuan Li, Biao Li, Xiaoxuan Li, Anyao Li, Qing-Chang Li, Hongliang Li, Dalei Li, Zongjun Li, Changqing Li, Hanting Li, Dong-Jie Li, Xiaomin Li, Dengxiong Li, Yi-Shuan J Li, Tinghao Li, Zhouxiang Li, Yun-tian Li, Jianliang Li, Guangzhao Li, Yixi Li, Shuyu Dan Li, S A Li, Jinjie Li, Liming Li, Wenqun Li, Guixia Li, Yinan Li, Aoxi Li, Yuanjing Li, Linqi Li, Xixi Li, Bingjue Li, Binghu Li, Yu-Hang Li, Shuhui Li, Mengying Li, Yihong Li, Yaxian Li, Dali Li, Zhiming Li, Xuemei Li, Xueting Li, Yongting Li, Hongxia Li, Zhenjun Li, Danyang Li, Tiandong Li, Di-Jie Li, Bo Li, Jinliang Li, Qiji Li, Zhipeng Li, Xiaoping Li, Linhong Li, Taoyingnan Li, Lieyou Li, Huabin Li, Mao Li, Yongchao Li, Xiaoting Li, Ruotai Li, Yaojia Li, Xiao-Yao Li, Shangming Li, Yaqi Li, Yibo Li, Gui-Hua Li, Zhihong Li, Yandong Li, Chaowei Li, Huiyuan Li, Yuchun Li, Boya Li, Lamei Li, O Li, Joyce Li, Suheng Li, Hui-Ping Li, Junru Li, Zhiqiang Li, Jiangchao Li, Hecheng Li, Yueping Li, Changkai Li, Zhenglong Li, Yajuan Li, Chaoqian Li, Yu-Cheng Li, Yirun Li, Haomiao Li, Qianqian Li, YiQing Li, Zhengliang Li, Weijie Li, Wei-Qin Li, Zongyi Li, Qingxian Li, Dan-Dan Li, Yeshan Li, Zirui Li, Keke Li, Yongpeng Li, Chanyuan Li, Jianbin Li, Shiying Li, Zhongzhe Li, Yumei Li, Xiang-Ping Li, Wenqiang Li, Pei-Shan Li, Zaibo Li, Guangming Li, Xiaoqiang Li, Hanxiao Li, Jiansheng Li, Shuying Li, Xiaomei Li, Pengjie Li, Jiajia Li, Jingwen Li
articles
Shiying Xie, Shicong Song, Sirui Liu +4 more · 2024 · Journal of translational medicine · BioMed Central · added 2026-04-24
(Pro)renin receptor (PRR) is highly expressed in renal tubules, which is involved in physiological and pathological processes. However, the role of PRR, expressed in renal tubular epithelial cells, in Show more
(Pro)renin receptor (PRR) is highly expressed in renal tubules, which is involved in physiological and pathological processes. However, the role of PRR, expressed in renal tubular epithelial cells, in diabetic kidney disease (DKD) remain largely unknown. In this study, kidney biopsies, urine samples, and public RNA-seq data from DKD patients were used to assess PRR expression and cell pyroptosis in tubular epithelial cells. The regulation of tubular epithelial cell pyroptosis by PRR was investigated by in situ renal injection of adeno-associated virus9 (AAV9)-shRNA into db/db mice, and knockdown or overexpression of PRR in HK-2 cells. To reveal the underlined mechanism, the interaction of PRR with potential binding proteins was explored by using BioGrid database. Furthermore, the direct binding of PRR to dipeptidyl peptidase 4 (DPP4), a pleiotropic serine peptidase which increases blood glucose by degrading incretins under diabetic conditions, was confirmed by co-immunoprecipitation assay and immunostaining. Higher expression of PRR was found in renal tubules and positively correlated with kidney injuries of DKD patients, in parallel with tubular epithelial cells pyroptosis. Knockdown of PRR in kidneys significantly blunted db/db mice to kidney injury by alleviating renal tubular epithelial cells pyroptosis and the resultant interstitial inflammation. Moreover, silencing of PRR blocked high glucose-induced HK-2 pyroptosis, whereas overexpression of PRR enhanced pyroptotic cell death of HK-2 cells. Mechanistically, PRR selectively bound to cysteine-enrich region of C-terminal of DPP4 and augmented the protein abundance of DPP4, leading to the downstream activation of JNK signaling and suppression of SIRT3 signaling and FGFR1 signaling, and then subsequently mediated pyroptotic cell death. This study identified the significant role of PRR in the pathogenesis of DKD; specifically, PRR promoted tubular epithelial cell pyroptosis via DPP4 mediated signaling, highlighting that PRR could be a promising therapeutic target in DKD. Show less
📄 PDF DOI: 10.1186/s12967-023-04846-5
FGFR1
Dan-Ling Dai, Chu Xie, Lan-Yi Zhong +27 more · 2024 · Signal transduction and targeted therapy · Nature · added 2026-04-24
Axis inhibition protein 1 (AXIN1), a scaffold protein interacting with various critical molecules, plays a vital role in determining cell fate. However, its impact on the antiviral innate immune respo Show more
Axis inhibition protein 1 (AXIN1), a scaffold protein interacting with various critical molecules, plays a vital role in determining cell fate. However, its impact on the antiviral innate immune response remains largely unknown. Here, we identify that AXIN1 acts as an effective regulator of antiviral innate immunity against both DNA and RNA virus infections. In the resting state, AXIN1 maintains the stability of the transcription factor interferon regulatory factor 3 (IRF3) by preventing p62-mediated autophagic degradation of IRF3. This is achieved by recruiting ubiquitin-specific peptidase 35 (USP35), which removes lysine (K) 48-linked ubiquitination at IRF3 K366. Upon virus infection, AXIN1 undergoes a phase separation triggered by phosphorylated TANK-binding kinase 1 (TBK1). This leads to increased phosphorylation of IRF3 and a boost in IFN-I production. Moreover, KYA1797K, a small molecule that binds to the AXIN1 RGS domain, enhances the AXIN1-IRF3 interaction and promotes the elimination of various highly pathogenic viruses. Clinically, patients with HBV-associated hepatocellular carcinoma (HCC) who show reduced AXIN1 expression in pericarcinoma tissues have low overall and disease-free survival rates, as well as higher HBV levels in their blood. Overall, our findings reveal how AXIN1 regulates IRF3 signaling and phase separation-mediated antiviral immune responses, underscoring the potential of the AXIN1 agonist KYA1797K as an effective antiviral agent. Show less
📄 PDF DOI: 10.1038/s41392-024-01978-y
AXIN1
Dandan Li, Pan Huang, Lingyun Xia +2 more · 2024 · International immunopharmacology · Elsevier · added 2026-04-24
The cancer-associated fibroblast (CAF)-derived secretome plays critical roles in tumor progression by remodelling tumor microenvironment. Tumorigenesis is accompanied by the transformation of normal f Show more
The cancer-associated fibroblast (CAF)-derived secretome plays critical roles in tumor progression by remodelling tumor microenvironment. Tumorigenesis is accompanied by the transformation of normal fibroblasts (NF) into CAF, leading to significant changes in their secretome. This work aims to identify the differential components of secretome between NFs and CAFs and reveal their functions in gastric cancer (GC). Firstly, our molecular typing studies and immune infiltration analysis showed that CAF infiltration level was increased and showed a significant association with clinical characteristics and poor prognosis of GC patients. Secondly, RNA-seq analysis revealed that a total of 1531 genes showed significant expression changes between NF and CAF. According to the annotation of the Human Protein Atlas (HPA) database, 147 genes encode secreted proteins, including FGF2. Particularly, the cell co-culture and RNA sequencing studies confirmed that exogenous recombinant FGF2 protein treatment promoted GC cell proliferation by enhancing ribosome biogenesis. The rescue assay showed that CAF-secreted FGF2 protein promotes GC cell growth and proliferation in a FGFR1-dependent manner. Our finding provides evidence that targeting blockade of CAF-derived FGF2 protein might be a promising treatment for GC. Show less
no PDF DOI: 10.1016/j.intimp.2024.111836
FGFR1
Wanrong Guo, Huanyi Cao, Yunfeng Shen +5 more · 2024 · Nutrition & diabetes · Nature · added 2026-04-24
The effectiveness of ketogenic diet (KD) in ameliorating fatty liver has been established, although its mechanism is under investigation. Fibroblast growth factor 21 (FGF21) positively regulates obesi Show more
The effectiveness of ketogenic diet (KD) in ameliorating fatty liver has been established, although its mechanism is under investigation. Fibroblast growth factor 21 (FGF21) positively regulates obesity-associated metabolic disorders and is elevated by KD. FGF21 conventionally initiates its intracellular signaling via receptor β-klotho (KLB). However, the mechanistic role of FGF21-KLB signaling for KD-ameliorated fatty liver remains unknown. This study aimed to delineate the critical role of FGF21 signaling in the ameliorative effects of KD on hepatic steatosis. Eight-week-old C57BL/6 J mice were fed a chow diet (CD), a high-fat diet (HFD), or a KD for 16 weeks. Adeno-associated virus-mediated liver-specific KLB knockdown mice and control mice were fed a KD for 16 weeks. Phenotypic assessments were conducted during and after the intervention. We investigated the mechanism underlying KD-alleviated hepatic steatosis using multi-omics and validated the expression of key genes. KD improved hepatic steatosis by upregulating fatty acid oxidation and downregulating lipogenesis. Transcriptional analysis revealed that KD dramatically activated FGF21 pathway, including KLB and fibroblast growth factor receptor 1 (FGFR1). Impairing liver FGF21 signaling via KLB knockdown diminished the beneficial effects of KD on ameliorating fatty liver, insulin resistance, and regulating lipid metabolism. KD demonstrates beneficial effects on diet-induced metabolic disorders, particularly on hepatic steatosis. Liver FGF21-KLB signaling plays a critical role in the KD-induced amelioration of hepatic steatosis. Show less
📄 PDF DOI: 10.1038/s41387-024-00277-3
FGFR1
Huaiguang Tang, Kongmiao Lu, Yan Wang +5 more · 2024 · European journal of medical research · BioMed Central · added 2026-04-24
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide. Catheter ablation has become a crucial treatment for AF. However, there is a possibility of atrial fibrillation recurrence aft Show more
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide. Catheter ablation has become a crucial treatment for AF. However, there is a possibility of atrial fibrillation recurrence after catheter ablation. Our study sought to elucidate the role of lncRNA‒mRNA regulatory networks in late AF recurrence after catheter ablation. We conducted RNA sequencing to profile the transcriptomes of 5 samples from the presence of recurrence after AF ablation (P-RAF) and 5 samples from the absence of recurrence after AF ablation (A-RAF). Differentially expressed genes (DEGs) and long noncoding RNAs (DE-lncRNAs) were analyzed using the DESeq2 R package. The functional correlations of the DEGs were assessed through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. A protein‒protein interaction (PPI) network was constructed using STRING and Cytoscape. We also established a lncRNA‒mRNA regulatory network between DE-lncRNAs and DEGs using BEDTools v2.1.2 software and the Pearson correlation coefficient method. To validate the high-throughput sequencing results of the hub genes, we conducted quantitative real-time polymerase chain reaction (qRT‒PCR) experiments. A total of 28,528 mRNAs and 42,333 lncRNAs were detected. A total of 96 DEGs and 203 DE-lncRNAs were identified between the two groups. GO analysis revealed that the DEGs were enriched in the biological processes (BPs) of "regulation of immune response" and "regulation of immune system process", the cellular components (CCs) of "extracellular matrix" and "cell‒cell junction", and the molecular functions (MFs) of "signaling adaptor activity" and "protein-macromolecule adaptor activity". According to the KEGG analysis, the DEGs were associated with the "PI3K-Akt signaling pathway" and "MAPK signaling pathway." Nine hub genes (MMP9, IGF2, FGFR1, HSPG2, GZMB, PEG10, GNLY, COL6A1, and KCNE3) were identified through the PPI network. lncRNA-TMEM51-AS1-201 was identified as a core regulator in the lncRNA‒mRNA regulatory network, suggesting its potential impact on the recurrence of AF after catheter ablation through the regulation of COL6A1, FGFR1, HSPG2, and IGF2. The recurrence of atrial fibrillation after catheter ablation may be associated with immune responses and fibrosis, with the extracellular matrix playing a crucial role. TMEM51-AS1-201 has been identified as a potential key target for AF recurrence after catheter ablation. Show less
📄 PDF DOI: 10.1186/s40001-024-01799-3
FGFR1
Miao Zheng, Can Wang, Min HU +5 more · 2024 · Metabolic brain disease · Springer · added 2026-04-24
Type 2 diabetes mellitus (T2DM) is a metabolic disorder that is characterized by insulin resistance and hyperglycemia. It is also known to be a risk factor for Alzheimer's disease (AD). Insulin plays Show more
Type 2 diabetes mellitus (T2DM) is a metabolic disorder that is characterized by insulin resistance and hyperglycemia. It is also known to be a risk factor for Alzheimer's disease (AD). Insulin plays a crucial role in regulating the body's metabolism and is responsible for activating the Phosphoinotide-3-Kinase (PI3K)/Protein Kinase B (Akt) signaling pathway. This pathway is activated when insulin binds to the insulin receptor on nerve cells, and it helps regulate the metabolism of glucose and lipids. Dysfunction in the insulin signaling pathway can lead to a decrease in brain insulin levels and insulin sensitivity, thereby inducing disruptions in insulin signal transduction and leading to disorders in brain energy metabolism. Moreover, these dysfunctions also contribute to the accumulation of β-amyloid (Aβ) deposition and the hyperphosphorylation of Tau protein, both of which are characteristic features of AD. Therefore, this article focuses on insulin resistance to reveal the complex mechanism between brain insulin resistance and AD occurrence in T2DM. On this basis, this article further summarizes the biological effects and mechanisms of antidiabetic drugs on the two diseases, aiming to provide new ideas for the discovery of drugs for the treatment of T2DM combined with AD. Show less
📄 PDF DOI: 10.1007/s11011-024-01472-y
BACE1
Junnan Hua, Ke Wang, Yue Chen +14 more · 2024 · Clinical and translational medicine · Wiley · added 2026-04-24
Hematopoietic stem and progenitor cells (HSPCs) possess the potential to produce all types of blood cells throughout their lives. It is well recognized that HSPCs are heterogeneous, which is of great Show more
Hematopoietic stem and progenitor cells (HSPCs) possess the potential to produce all types of blood cells throughout their lives. It is well recognized that HSPCs are heterogeneous, which is of great significance for their clinical applications and the treatment of diseases associated with HSPCs. This study presents a novel technology called Single-Cell transcriptome Analysis and Lentiviral Barcoding (SCALeBa) to investigate the molecular mechanisms underlying the heterogeneity of human HSPCs in vivo. The SCALeBa incorporates a transcribed barcoding library and algorithm to analyze the individual cell fates and their gene expression profiles simultaneously. Our findings using SCALeBa reveal that HSPCs subset with stronger stemness highly expressed MYL6B, ATP2A2, MYO19, MDN1, ING3, and so on. The high expression of COA3, RIF1, RAB14, and GOLGA4 may contribute to the pluripotent-lineage differentiation of HSPCs. Moreover, the roles of the representative genes revealed in this study regarding the stemness of HPSCs were confirmed with biological experiments. HSPCs expressing MRPL23 and RBM4 genes may contribute to differentiation bias into myeloid and lymphoid lineage, respectively. In addition, transcription factor (TF) characteristics of lymphoid and myeloid differentiation bias HSPCs subsets were identified and linked to previously identified genes. Furthermore, the stemness, pluripotency, and differentiation-bias genes identified with SCALeBa were verified in another independent HSPCs dataset. Finally, this study proposes using the SCALeBa-generated tracking trajectory to improve the accuracy of pseudo-time analysis results. In summary, our study provides valuable insights for understanding the heterogeneity of human HSPCs in vivo and introduces a novel technology, SCALeBa, which holds promise for broader applications. KEY POINTS: SCALeBa and its algorithm are developed to study the molecular mechanism underlying human HSPCs identity and function. The human HSPCs expressing MYL6B, MYO19, ATP2A2, MDN1, ING3, and PHF20 may have the capability for high stemness. The human HSPCs expressing COA3, RIF1, RAB14, and GOLGA4 may have the capability for pluripotent-lineage differentiation. The human HSPCs expressing MRPL23 and RBM4 genes may have the capability to differentiate into myeloid and lymphoid lineage respectively in vivo. The legitimacy of the identified genes with SCALeBa was validated using biological experiments and a public human HSPCs dataset. SCALeBa improves the accuracy of differentiation trajectories in monocle2-based pseudo-time analysis. Show less
no PDF DOI: 10.1002/ctm2.70085
MYO19
Xuehui Long, Sulin Zhang, Yuliang Wang +22 more · 2024 · Nature immunology · Nature · added 2026-04-24
Regulatory T (T
📄 PDF DOI: 10.1038/s41590-024-01746-8
JMJD1C
Zixuan Wu, Na Li, Yuan Gao +3 more · 2024 · BMC genomics · BioMed Central · added 2026-04-24
Nonspecific orbital inflammation (NSOI) is an idiopathic, persistent, and proliferative inflammatory condition affecting the orbit, characterized by polymorphous lymphoid infiltration. Its pathogenesi Show more
Nonspecific orbital inflammation (NSOI) is an idiopathic, persistent, and proliferative inflammatory condition affecting the orbit, characterized by polymorphous lymphoid infiltration. Its pathogenesis and progression have been linked to imbalances in tumor metabolic pathways, with glutamine (Gln) metabolism emerging as a critical aspect in cancer. Metabolic reprogramming is known to influence clinical outcomes in various malignancies. However, comprehensive research on glutamine metabolism's significance in NSOI is lacking. This study conducted a bioinformatics analysis to identify and validate potential glutamine-related molecules (GlnMgs) associated with NSOI. The discovery of GlnMgs involved the intersection of differential expression analysis with a set of 42 candidate GlnMgs. The biological functions and pathways of the identified GlnMgs were analyzed using GSEA and GSVA. Lasso regression and SVM-RFE methods identified hub genes and assessed the diagnostic efficacy of fourteen GlnMgs in NSOI. The correlation between hub GlnMgs and clinical characteristics was also examined. The expression levels of the fourteen GlnMgs were validated using datasets GSE58331 and GSE105149. Fourteen GlnMgs related to NSOI were identified, including FTCD, CPS1, CTPS1, NAGS, DDAH2, PHGDH, GGT1, GCLM, GLUD1, ART4, AADAT, ASNSD1, SLC38A1, and GFPT2. Biological function analysis indicated their involvement in responses to extracellular stimulus, mitochondrial matrix, and lipid transport. The diagnostic performance of these GlnMgs in distinguishing NSOI showed promising results. This study successfully identified fourteen GlnMgs associated with NSOI, providing insights into potential novel biomarkers for NSOI and avenues for monitoring disease progression. Show less
📄 PDF DOI: 10.1186/s12864-023-09946-6
CPS1
Liqing Ke, Qifei He, Jing Qu +14 more · 2024 · Molecular therapy : the journal of the American Society of Gene Therapy · Elsevier · added 2026-04-24
Despite recent advances, rheumatoid arthritis (RA) patients remain refractory to therapy. Dysregulated overproduction of angiopoietin-like protein 4 (ANGPTL4) is thought to contribute to the disease d Show more
Despite recent advances, rheumatoid arthritis (RA) patients remain refractory to therapy. Dysregulated overproduction of angiopoietin-like protein 4 (ANGPTL4) is thought to contribute to the disease development. ANGPTL4 was initially identified as a regulator of lipid metabolism, which is hydrolyzed to N-terminal and C-terminal (cANGPTL4) fragments in vivo. cANGPTL4 is involved in several non-lipid-related processes, including angiogenesis and inflammation. This study revealed that the level of ANGPTL4 was markedly elevated in the sera and synovial tissues from patients with RA versus controls. The administration of a neutralizing antibody against cANGPTL4 (anti-cANGPTL4 Ab) resulted in the inhibition of inflammatory processes and bone loss in animal models of collagen-induced arthritis and adjuvant-induced arthritis (AIA). Transcriptomic and proteomic profiling of synovial tissues from an AIA model indicated that the anti-cANGPTL4 Ab inhibited fibroblast-like synoviocyte (FLS) immigration and inflammatory-induced osteoclastogenesis. Mechanistically, the anti-cANGPTL4 Ab has been shown to inhibit TNF-α-induced inflammatory cascades in RA-FLS through the sirtuin 1/nuclear factor-κB signaling pathway. Moreover, the anti-cANGPTL4 Ab was found to block FLS invasion- and immigration-induced osteoclast activation. Collectively, these findings identify ANGPTL4 as a prospective biomarker for the diagnosis of RA, and targeting cANGPTL4 should represent a potential therapeutic strategy. Show less
no PDF DOI: 10.1016/j.ymthe.2024.09.031
ANGPTL4
Bingxin Xu, Jindong Yao, Wenqi Song +11 more · 2024 · ACS pharmacology & translational science · ACS Publications · added 2026-04-24
Melanocortin-4 receptor (MC4R) functions as a crucial neuroendocrine G protein-coupled receptor (GPCR) in the central nervous system of mammals, displaying agonist-independent constitutive activity th Show more
Melanocortin-4 receptor (MC4R) functions as a crucial neuroendocrine G protein-coupled receptor (GPCR) in the central nervous system of mammals, displaying agonist-independent constitutive activity that is mainly determined by its N-terminal domain. We previously reported that zebrafish MC4R exhibited a much higher basal cAMP level in comparison to mammalian MC4Rs. However, the functional evolution of constitutive activities in chordate MC4Rs remains to be elucidated. Here we cloned and compared the constitutive activities of MC4Rs from nine vertebrate species and showed that the additive action of the N-terminus with the extracellular region or transmembrane domain exhibited a combined pharmacological effect on the MC4R constitutive activity. In addition, we demonstrated that four residues of F149, Q156, V163, and K164 of the second intracellular loop played a vital role in determining MC4R constitutive activity. This study provided novel insights into functional evolution and identified a key motif essential for constitutive modulation of MC4R signaling. Show less
no PDF DOI: 10.1021/acsptsci.3c00169
MC4R
Jordi Rodón, Silvia Damian, Muhammad Furqan +12 more · 2024 · Nature medicine · Nature · added 2026-04-24
no PDF DOI: 10.1038/s41591-024-03072-w
FGFR1
Ewa Karwatowska-Prokopczuk, Anastasia Lesogor, Jing-He Yan +4 more · 2024 · Lipids in health and disease · BioMed Central · added 2026-04-24
Olezarsen is a GalNAc A randomized, placebo-controlled, double-blind phase 1 study was performed in 28 healthy Japanese American participants treated with olezarsen in single-ascending doses (SAD; 30, Show more
Olezarsen is a GalNAc A randomized, placebo-controlled, double-blind phase 1 study was performed in 28 healthy Japanese American participants treated with olezarsen in single-ascending doses (SAD; 30, 60, 90 mg) or multiple doses (MD; 60 mg every 4 weeks for 4 doses). The primary, secondary, and exploratory objectives were safety and tolerability, pharmacokinetics, and effects of olezarsen on fasting serum triglycerides and apoC-III, respectively. There were 20 participants (16 active:4 placebo) in the SAD part of the study, and 8 participants (6 active:2 placebo) in the MD part of the study. For the primary endpoint, no serious adverse events or clinically relevant laboratory abnormalities were reported. The majority of olezarsen plasma exposure occurred within 24 h post-dose. In the SAD cohorts at Day 15 the percentage reduction in apoC-III/TG was - 39.4%/ - 17.8%, - 60.8%/ - 52.7%, and - 68.1%/ - 39.2% in the 30, 60 and 90 mg doses, respectively, vs 2.3%/44.5% increases in placebo. In the MD cohort, at Day 92 the percentage reduction in apoC-III/TG was - 81.6/ - 73.8% vs - 17.2/ - 40.8% reduction in placebo. Favorable changes were also present in VLDL-C, apoB and HDL-C. Single- and multiple-dose administration of olezarsen was safe, was well tolerated, and significantly reduced apoC-III and triglyceride levels in healthy Japanese Americans. Show less
📄 PDF DOI: 10.1186/s12944-024-02297-5
APOB
Hanjie Liu, Hui Yang, Shuqing Liu +7 more · 2024 · Journal of visualized experiments : JoVE · added 2026-04-24
Many sex-specific biomarkers have been recently revealed in Alzheimer's disease (AD); however, cerebral glial cells were rarely reported. This study analyzed 220,095 single-nuclei transcriptomes from Show more
Many sex-specific biomarkers have been recently revealed in Alzheimer's disease (AD); however, cerebral glial cells were rarely reported. This study analyzed 220,095 single-nuclei transcriptomes from the frontal cortex of thirty-three AD individuals in the GEO database. Sex-specific Differentially Expressed Genes (DEGs) were identified in glial cells, including 243 in astrocytes, 1,154 in microglia, and 572 in oligodendrocytes. Gene Ontology (GO) functional annotation analyses and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses revealed functional concentration in synaptic, neural, and hormone-related pathways. Protein-protein interaction network (PPI) identified MT3, CALM2, DLG2, KCND2, PAKACB, CAMK2D, and NLGN4Y in astrocytes, TREM2, FOS, APOE, APP, and NLGN4Y in microglia, and GRIN2A, ITPR2, GNAS, and NLGN4Y in oligodendrocytes as key genes. NLGN4Y was the only gene shared by the three glia and was identified as the biomarker for the gender specificity of AD. Gene-transcription factor (TF)-miRNA coregulatory network identified key regulators for NLGN4Y and its target TCMs. Ecklonia kurome Okam (Kunbu) and Herba Ephedrae (Mahuang) were identified, and the effects of the active ingredients on AD were displayed. Finally, enrichment analysis of Kunbu and Mahuang suggested that they might act as therapeutic candidates for gender specificity of AD. Show less
no PDF DOI: 10.3791/66552
DLG2
Katherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari +14 more · 2024 · JCO precision oncology · added 2026-04-24
BRAF and MEK inhibitors are standard treatments in histiocytic disorders, such as Erdheim-Chester disease (ECD). Some patients lack MAPK-pathway alterations, making these treatments less effective. We Show more
BRAF and MEK inhibitors are standard treatments in histiocytic disorders, such as Erdheim-Chester disease (ECD). Some patients lack MAPK-pathway alterations, making these treatments less effective. We describe three patients with histiocytic disorders who have novel non-MAPK pathway alterations. These alterations were studied through genomic and in silico analyses when applicable, then treated with off-label medications rationally selected on the basis of genomic alterations. Patient 1 had rapidly progressive ECD involving the CNS. A CSF1R in-frame deletion (p.S560_P566del) was identified, and in silico modeling predicted a gain-of-function mutation. This alteration was targeted with pexidartinib, which led to a clinical complete response (CR) within 2 months, and a partial response (PR) on imaging after 3 months. After 15 months, the disease became resistant to pexidartinib and transformed to histiocytic sarcoma. Patient 2 has skin-only involvement of a xanthogranuloma disorder. A KIF5B-FGFR1 fusion was identified on RNA sequencing and targeted with pemigatinib. At 24 months of follow-up, she remains in a clinical PR. Patient 3 has ECD involving the bone marrow, gastrointestinal tract, and subcutaneous tissues. A MEF2C-FLT3 fusion was identified and targeted with sorafenib. He achieved a clinical CR and radiographic PR within 3 months, which has continued for 30 months. We report three patients with histiocytic disorders harboring novel alterations who had sustained responses to off-label kinase inhibitors specific to their histiocytic disorder. Pathogenic variants outside of the MAPK pathway, including variants of unknown significant, may be targeted with readily available small molecules. Show less
📄 PDF DOI: 10.1200/PO-24-00471
FGFR1
Binbin Wang, Ningyan Li, Zhenghua Ju +1 more · 2024 · Inorganic chemistry · ACS Publications · added 2026-04-24
Metal-organic hybrid materials with long persistent luminescence (LPL) properties have attracted a lot of attention due to their enormous potential for applications in information encryption, anticoun Show more
Metal-organic hybrid materials with long persistent luminescence (LPL) properties have attracted a lot of attention due to their enormous potential for applications in information encryption, anticounterfeiting, and other correlation fields. However, achieving multimodal luminescence in a single component remains a significant challenge. Herein, we report two two-dimensional LPL coordination polymers: {[Zn Show less
no PDF DOI: 10.1021/acs.inorgchem.4c04414
LPL
Hongsen Lv, Anxiang Wang, Jingning Ling +7 more · 2024 · Comparative biochemistry and physiology. Part D, Genomics & proteomics · Elsevier · added 2026-04-24
To explore the patterns of differentially expressed genes (DEGs) associated with different growth rates in rock carp (Procypris rabaudi), transcriptome sequencing was performed on the muscle, liver, a Show more
To explore the patterns of differentially expressed genes (DEGs) associated with different growth rates in rock carp (Procypris rabaudi), transcriptome sequencing was performed on the muscle, liver, and brain tissues of rock carp. Subsequently, bioinformatics analysis was conducted, and 2129, 1380, and 415 DEGs were identified in the muscle, liver, and brain tissues, respectively. GO enrichment and KEGG pathway analysis revealed that genes related to appetite regulation, protein degradation and digestion, lipid transport and metabolisms, and glycolysis/gluconeogenesis were upregulated in individuals with slower growth rates. Differential expression analysis identified 21 genes associated with feeding and metabolism across three tissues, including mc4r, npy, and npry in brain tissue; fatp, fabp, pparα, and apo in liver tissue; and prss, ctrl, and cela in muscle tissue. All these genes were upregulated in the slow-growing fish. Furthermore, weighted gene co-expression network analyses, including three modules (yellow, turquoise, and brown), significantly associated with growth. A network map that included these three modules enabled the identification of a series of hub genes, including rp13a, ube2o, h6pd, etc. These genes may be key candidate genes regulating the growth of rock carp. This study contributes to a deeper understanding of the growth control mechanism in rock carp and offers a scientific basis for efficient breeding and species improvement. Show less
no PDF DOI: 10.1016/j.cbd.2024.101337
MC4R
Xilin Ge, Caoxin Huang, Wenting Chen +4 more · 2024 · European journal of histochemistry : EJH · added 2026-04-24
Retinopathy is a common complication of diabetes mellitus and the leading cause of visual impairment. Danggui Buxue decoction (RRP) has been used as a traditional drug for the treatment of diabetic ne Show more
Retinopathy is a common complication of diabetes mellitus and the leading cause of visual impairment. Danggui Buxue decoction (RRP) has been used as a traditional drug for the treatment of diabetic nephropathy for many years. The aim of this study was to investigate the effects of RRP on hypoxia-induced retinal Müller cell injury. A model of retinal Müller cell damage was created using high glucose levels (25 mmol/L) and/or exposure to low oxygen conditions (1% O2). RRP was given to rats by continuous gavage for 7 days to obtain drug-containing serum. After sterilization, the serum was added to the culture medium at a ratio of 10%. Cell viability, apoptosis, and cell proliferation were assessed using the CCK-8 kit, Annexin V-FITC/propidium iodide apoptosis kit, and EdU kit. The mRNA levels of angiogenesis factors (ANGPTL4, VEGF) and inflammatory factors (IL-1B, ICAM-1) were detected by RT-qPCR. Western blot analysis was employed to assess the levels of proteins related to the ATF4/CHOP pathway. Following hypoxia for 48 h and 72 h, there was a significant decrease in cell viability and proliferation, as well as a notable increase in apoptosis compared to the control group (21% O2). However, high glucose stimulation had no significant effect, and high glucose combined with hypoxia had no further damage to cells. After 48 h of exposure to low oxygen levels, the mRNA expression levels of ANGPTL4, VEGF, IL-1B, and ICAM-1 in retinal Müller cells were significantly higher than in the control group (21% O2). RRP treatment significantly alleviated the increase of cell apoptosis and the upregulation of IL-1B and-1 in retinal Müller cells induced by hypoxia. RRP has the potential to reduce the suppression of the ATF4/CHOP pathway in hypoxia-induced retinal Müller cells, and it significantly alleviates cell apoptosis through regulating inflammatory factors and the ATF4/CHOP pathway. Show less
📄 PDF DOI: 10.4081/ejh.2024.4140
ANGPTL4
Sen Lin, Lanyue Ma, Jiaxin Mo +5 more · 2024 · Aging · Impact Journals · added 2026-04-24
Liver metastasis (LM) stands as a primary cause of mortality in metastatic colorectal cancer (mCRC), posing a significant impediment to long-term survival benefits from targeted therapy and immunother Show more
Liver metastasis (LM) stands as a primary cause of mortality in metastatic colorectal cancer (mCRC), posing a significant impediment to long-term survival benefits from targeted therapy and immunotherapy. However, there is currently a lack of comprehensive investigation into how senescent and exhausted immune cells contribute to LM. We gathered single-cell sequencing data from primary colorectal cancer (pCRC) and their corresponding matched LM tissues from 16 mCRC patients. In this study, we identified senescent and exhausted immune cells, performed enrichment analysis, cell communication, cell trajectory, and cell-based We identified senescent-like myeloid cells (SMCs) and exhausted T cells (TEXs) as the primary senescent and exhausted immune cells. Our findings indicate that SMCs and TEXs can potentially activate transcription factors downstream via ANGPTL4-SDC1/SDC4, this activation plays a role in regulating the epithelial-mesenchymal transition (EMT) program and facilitates the development of LM, the results of cell-based This study elucidates the potential molecular mechanisms underlying the occurrence of LM from various angles through single-cell multi-omics analysis in CRC. It also constructs a network illustrating the role of senescent or exhausted immune cells in regulating EMT. Show less
📄 PDF DOI: 10.18632/aging.205778
ANGPTL4
Zhao Yang, Mengran Shi, Youfeng Liang +20 more · 2024 · Journal of gastroenterology · Springer · added 2026-04-24
Three-dimensional (3D) chromatin architecture frequently altered in cancer. However, its changes during the pathogenesis of hepatocellular carcinoma (HCC) remained elusive. Hi-C and RNA-seq were appli Show more
Three-dimensional (3D) chromatin architecture frequently altered in cancer. However, its changes during the pathogenesis of hepatocellular carcinoma (HCC) remained elusive. Hi-C and RNA-seq were applied to study the 3D chromatin landscapes and gene expression of HCC and ANHT. Hi-C Pro was used to generate genome-wide raw interaction matrices, which were normalized via iterative correction (ICE). Moreover, the chromosomes were divided into different compartments according to the first principal component (E1). Furthermore, topologically associated domains (TADs) were visualized via WashU Epigenome Browser. Furthermore, differential expression analysis of ANHT and HCC was performed using the DESeq2 R package. Additionally, dysregulated genes associated with 3D genome architecture altered were confirmed using TCGA, qRT-PCR, immunohistochemistry (IHC), etc. RESULTS: First, the intrachromosomal interactions of chr1, chr2, chr5, and chr11 were significantly different, and the interchromosomal interactions of chr4-chr10, chr13-chr21, chr15-chr22, and chr16-chr19 are remarkably different between ANHT and HCC, which resulted in the up-regulation of TP53I3 and ZNF738 and the down-regulation of APOC3 and APOA5 in HCC. Second, 49 compartment regions on 18 chromosomes have significantly switched (A-B or B-A) during HCC tumorigenesis, contributing to up-regulation of RAP2A. Finally, a tumor-specific TAD boundary located on chr5: 6271000-6478000 and enhancer hijacking were identified in HCC tissues, potentially associated with the elevated expression of MED10, whose expression were associated with poor prognosis of HCC patients. This study demonstrates the crucial role of chromosomal structure variation in HCC oncogenesis and potential novel biomarkers of HCC, laying a foundation for cancer precision medicine development. Show less
📄 PDF DOI: 10.1007/s00535-023-02053-z
APOA5
Lingfeng Yang, Xiang Li, Yueze Wang +2 more · 2024 · IEEE transactions on pattern analysis and machine intelligence · IEEE · added 2026-04-24
Vision-Language Models (VLMs), such as CLIP, excel in zero-shot image-level visual understanding but struggle with object-based tasks requiring precise localization and recognition. Visual prompts, li Show more
Vision-Language Models (VLMs), such as CLIP, excel in zero-shot image-level visual understanding but struggle with object-based tasks requiring precise localization and recognition. Visual prompts, like colorful boxes or circles, are suggested to enhance local perception. However, these methods often include irrelevant and noisy pixels, leading to suboptimal performance. The design of better visual prompts and their collaboration with text prompting remains underexplored. This paper introduces Fine-Grained Visual Text Prompting (FGVTP), a new zero-shot framework for object-based tasks using precise semantic masks and reinforced image-text alignment. FGVTP comprises Fine-Grained Visual Prompting (FGVP) and Consistency-Enhanced Text Prompting (CETP). Specifically, we carefully study visual prompting designs by exploring more visual markings that vary in shape and form. FGVP uses semantic masks from a segmenter like the Segment Anything Model (SAM) and employs background blurring (Blur Reverse Mask) to highlight targets while maintaining spatial coherence. Further, CETP enhances image-text alignment by prompting captions based on FGVP-processed images. As a result, FGVTP achieves superior zero-shot referring expression comprehension on RefCOCO/+/g benchmarks, outperforming previous SOTA methods by 5.8% on average. Part detection experiments conducted on the PACO dataset further validate the preponderance of FGVTP over existing works. Code is available at https://github.com/ylingfeng/FGVP. Show less
no PDF DOI: 10.1109/TPAMI.2024.3504568
CETP
Jingteng Chen, Ling Yu, Tian Gao +11 more · 2024 · Bioactive materials · Elsevier · added 2026-04-24
Magnesium phosphate bone cements (MPC) have been recognized as a viable alternative for bone defect repair due to their high mechanical strength and biodegradability. However, their poor porosity and Show more
Magnesium phosphate bone cements (MPC) have been recognized as a viable alternative for bone defect repair due to their high mechanical strength and biodegradability. However, their poor porosity and permeability limit osteogenic cell ingrowth and vascularization, which is critical for bone regeneration. In the current study, we constructed a novel hierarchically-porous magnesium phosphate bone cement by incorporating extracellular matrix (ECM)-mimicking electrospun silk fibroin (SF) nanofibers. The SF-embedded MPC (SM) exhibited a heterogeneous and hierarchical structure, which effectively facilitated the rapid infiltration of oxygen and nutrients as well as cell ingrowth. Besides, the SF fibers improved the mechanical properties of MPC and neutralized the highly alkaline environment caused by excess magnesium oxide. Bone marrow stem cells (BMSCs) adhered excellently on SM, as illustrated by formation of more pseudopodia. CCK8 assay showed that SM promoted early proliferation of BMSCs. Our study also verified that SM increased the expression of OPN, RUNX2 and BMP2, suggesting enhanced osteogenic differentiation of BMSCs. We screened for osteogenesis-related pathways, including FAK signaing, Wnt signaling and Notch signaling, and found that SM aided in the process of bone regeneration by suppressing the Notch signaling pathway, proved by the downregulation of NICD1, Hes1 and Hey2. In addition, using a bone defect model of rat calvaria, the study revealed that SM exhibited enhanced osteogenesis, bone ingrowth and vascularization compared with MPC alone. No adverse effect was found after implantation of SM Show less
📄 PDF DOI: 10.1016/j.bioactmat.2024.03.021
HEY2
Jeffrey Wang, Weiwei Zhang, Xinjie Xu +13 more · 2024 · Human pathology · Elsevier · added 2026-04-24
The PICALM::MLLT10 fusion is a rare but recurrent cytogenetic abnormality in acute leukemia, with limited clinicopathologic and outcome data available. Herein, we analyzed 156 acute leukemia patients Show more
The PICALM::MLLT10 fusion is a rare but recurrent cytogenetic abnormality in acute leukemia, with limited clinicopathologic and outcome data available. Herein, we analyzed 156 acute leukemia patients with PICALM::MLLT10 fusion, including 12 patients from our institutions and 144 patients from the literature. The PICALM::MLLT10 fusion preferentially manifested in pediatric and young adult patients, with a median age of 24 years. T-lymphoblastic leukemia/lymphoma (T-ALL) constituted 65% of cases, acute myeloid leukemia (AML) 27%, and acute leukemia of ambiguous lineage (ALAL) 8%. About half of T-ALL were classified as an early T-precursor (ETP)-ALL. In our institutions' cohort, mediastinum was the most common extramedullary site of involvement. Eight of 12 patients were diagnosed with T-ALL exhibiting a pro-/pre-T stage phenotype (CD4/CD8-double negative, CD7-positive), and frequent CD79a expression. NGS revealed pathogenic mutations in 5 of 6 tested cases, including NOTCH1, and genes in RAS and JAK-STAT pathways and epigenetic modifiers. Of 138 cases with follow-up, pediatric patients (<18 years) had 5-year overall survival (OS) of 71%, significantly better than adults at 33%. The 5-year OS for AML patients was 25%, notably shorter than T-ALL patients at 54%; this distinction was observed in both pediatric and adult populations. Furthermore, adult but not pediatric ETP-ALL patients demonstrated inferior survival compared to non-ETP-ALL patients. Neither karyotype complexity nor transplant status had a discernible impact on OS. In conclusion, PICALM::MLLT10 fusion is most commonly seen in T-ALL patients, particularly those with an ETP phenotype. AML and adult ETP-ALL patients had adverse prognosis. PICALM::MLTT10 fusion testing should be considered in T-ALL, AML, and ALAL patients. Show less
no PDF DOI: 10.1016/j.humpath.2024.07.003
MLLT10
Junfeng Wu, Tao Chen, Minghang Zhang +5 more · 2024 · Archives of toxicology · Springer · added 2026-04-24
Steroid-induced osteonecrosis of the femoral head (SONFH) is a prevalent form of osteonecrosis in young individuals. More efficacious clinical strategies must be used to prevent and treat this conditi Show more
Steroid-induced osteonecrosis of the femoral head (SONFH) is a prevalent form of osteonecrosis in young individuals. More efficacious clinical strategies must be used to prevent and treat this condition. One of the mechanisms through which SONFH operates is the disruption of normal differentiation in bone marrow adipocytes and osteoblasts due to prolonged and extensive use of glucocorticoids (GCs). In vitro, it was observed that atorvastatin (ATO) effectively suppressed the impact of dexamethasone (DEX) on bone marrow mesenchymal stem cells (BMSCs), specifically by augmenting their lipogenic differentiation while impeding their osteogenic differentiation. To investigate the underlying mechanisms further, we conducted transcriptome sequencing of BMSCs subjected to different treatments, leading to the identification of Wnt5a as a crucial gene regulated by ATO. The analyses showed that ATO exhibited the ability to enhance the expression of Wnt5a and modulate the MAPK pathway while regulating the Wnt canonical signaling pathway via the WNT5A/LRP5 pathway. Our experimental findings provide further evidence that the combined treatment of ATO and DEX effectively mitigates the effects of DEX, resulting in the upregulation of osteogenic genes (Runx2, Alpl, Tnfrsf11b, Ctnnb1, Col1a) and the downregulation of adipogenic genes (Pparg, Cebpb, Lpl), meanwhile leading to the upregulation of Wnt5a expression. So, this study offers valuable insights into the potential mechanism by which ATO can be utilized in the prevention of SONFH, thereby holding significant implications for the prevention and treatment of SONFH in clinical settings. Show less
📄 PDF DOI: 10.1007/s00204-024-03817-z
LPL
Ye-Ran Wang, Xiao-Qin Zeng, Jun Wang +10 more · 2024 · Acta neuropathologica · Springer · added 2026-04-24
The profile of autoantibodies is dysregulated in patients with Alzheimer's disease (AD). Autoantibodies to beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1) are present in human bloo Show more
The profile of autoantibodies is dysregulated in patients with Alzheimer's disease (AD). Autoantibodies to beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1) are present in human blood. This study aims to investigate the clinical relevance and pathophysiological roles of autoantibodies to BACE1 in AD. Clinical investigations were conducted in two independent cohorts, the Chongqing cohort, and the Australian Imaging, Biomarkers, and Lifestyle (AIBL) cohort. The Chongqing cohort included 55 AD patients, 28 patients with non-AD dementia, and 70 cognitively normal subjects (CN). The AIBL cohort included 162 Aβ-PET Show less
📄 PDF DOI: 10.1007/s00401-024-02814-x
BACE1
Yan Ding, Zhixuan Chen, Huaxuan Wen +5 more · 2024 · Cerebellum (London, England) · Springer · added 2026-04-24
This was a study of 12 cerebellar cortical dysplasias (CCDs) fetuses, these cases were characterized by a disorder of cerebellar fissures. Historically, CCD diagnosis was primarily performed using pos Show more
This was a study of 12 cerebellar cortical dysplasias (CCDs) fetuses, these cases were characterized by a disorder of cerebellar fissures. Historically, CCD diagnosis was primarily performed using postnatal imaging. Unique to this study was the case series of CCD for prenatal diagnosis using prenatal ultrasound, as well as we found that AXIN1 and FOXC1 mutations may be related to CCD. Show less
no PDF DOI: 10.1007/s12311-024-01688-9
AXIN1
Bihui Jin, Guanyu Su, Xiao Zhou +6 more · 2024 · Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · added 2026-04-24
no PDF DOI: 10.1089/jop.2024.0042
FGFR1
Xuhan Wu, Wenqing Li, Shengjie Li +4 more · 2024 · International journal of biological macromolecules · Elsevier · added 2026-04-24
Sargassum fusiforme is a brown seaweed that grows abundantly along the rocky coastlines of Asian countries. The polysaccharides derived from Sargassum fusiforme (SFPS) have received much interest due Show more
Sargassum fusiforme is a brown seaweed that grows abundantly along the rocky coastlines of Asian countries. The polysaccharides derived from Sargassum fusiforme (SFPS) have received much interest due to their various bioactivities, such as hypolipidemic, hypoglycemic, and antioxidant activities. In this study, we extracted and purified SFPS, and obtained the ultrasonic degradation product (SFPSUD). The lipid regulatory effects of SFPS and SFPSUD were investigated in a zebrafish model fed a high-fat diet. The results showed that SFPS significantly decreased the levels of total cholesterol (TC) and triglycerides (TG), and increased the activities of lipoprotein lipase (LPL) and hepatic lipase (HL). SFPSUD was more effective than the SFPS in reducing the TC and TG levels in zebrafish, as well as increasing the LPL and HL activities. Histopathological observations of zebrafish livers showed that SFPSUD significantly improved lipid metabolism disorder in the hepatocytes. The possible lipid-lowering mechanism in zebrafish associated with SFPS and SFPSUD may involve acceleration of the lipid metabolism rate by increasing the activities of LPL and HL. Thus, SFPSUD could be tested as a highly effective hypolipidemic drug. Our results suggest that SFPS and SFPSUD have potential uses as functional foods for the prevention and treatment of hyperlipidemia. Ultrasound can be effectively applied to degrade SFPS to improve its physicochemical properties and bioactivities. Show less
no PDF DOI: 10.1016/j.ijbiomac.2024.133771
LPL
Jiwei Jiang, Yaou Liu, Anxin Wang +11 more · 2024 · Chinese medical journal · added 2026-04-24
Few evidence is available in the early prediction models of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD). This study aimed to develop and validate a novel genet Show more
Few evidence is available in the early prediction models of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD). This study aimed to develop and validate a novel genetic-clinical-radiological nomogram for evaluating BPSD in patients with AD and explore its underlying nutritional mechanism. This retrospective study included 165 patients with AD from the Chinese Imaging, Biomarkers, and Lifestyle (CIBL) cohort between June 1, 2021, and March 31, 2022. Data on demographics, neuropsychological assessments, single-nucleotide polymorphisms of AD risk genes, and regional brain volumes were collected. A multivariate logistic regression model identified BPSD-associated factors, for subsequently constructing a diagnostic nomogram. This nomogram was internally validated through 1000-bootstrap resampling and externally validated using a time-series split based on the CIBL cohort data between June 1, 2022, and February 1, 2023. Area under receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) were used to assess the discrimination, calibration, and clinical applicability of the nomogram. Factors independently associated with BPSD were: CETP rs1800775 (odds ratio [OR] = 4.137, 95% confidence interval [CI]: 1.276-13.415, P  = 0.018), decreased Mini Nutritional Assessment score (OR = 0.187, 95% CI: 0.086-0.405, P  <0.001), increased caregiver burden inventory score (OR = 8.993, 95% CI: 3.830-21.119, P  <0.001), and decreased brain stem volume (OR = 0.006, 95% CI: 0.001-0.191, P  = 0.004). These variables were incorporated into the nomogram. The area under the ROC curve was 0.925 (95% CI: 0.884-0.967, P  <0.001) in the internal validation and 0.791 (95% CI: 0.686-0.895, P  <0.001) in the external validation. The calibration plots showed favorable consistency between the prediction of nomogram and actual observations, and the DCA showed that the model was clinically useful in both validations. A novel nomogram was established and validated based on lipid metabolism-related genes, nutritional status, and brain stem volumes, which may allow patients with AD to benefit from early triage and more intensive monitoring of BPSD. Chictr.org.cn , ChiCTR2100049131. Show less
📄 PDF DOI: 10.1097/CM9.0000000000002914
CETP
Jianing Wu, Ke Ma, Jie Ma +2 more · 2024 · Clinica chimica acta; international journal of clinical chemistry · Elsevier · added 2026-04-24
A poor prognosis is associated with atherosclerotic plaque rupture (PR) despite after conventional therapy for patients with acute coronary syndrome (ACS). Timely identification of PR improves the ris Show more
A poor prognosis is associated with atherosclerotic plaque rupture (PR) despite after conventional therapy for patients with acute coronary syndrome (ACS). Timely identification of PR improves the risk stratification and prognosis of ACS patients. A derivation cohort of 110 patients with ACS who underwent pre-intervention optical coherence tomography (OCT) were matched 1:1 to the PR and intact fibrous cap (IFC) groups according to traditional risk factors. Candidate PR proteins were identified via mass spectrometry (MS)-based proteomics using unbiased machine learning methods and were further validated by enzyme-linked immunosorbent assay (ELISA) in an external validation cohort of 85 patients with ACS. The performance of candidate biomakers was assessed using the receiver operating characteristic curve analysis. 1121 proteins were identified and 535 filtered proteins were used for analysis. Nine candidate proteins were screened by five machine learning algorithms. Three proteins (APOC3, RAB39A, and KNG1) were significantly different between the PR and IFC in validation cohort. The performance of plasm APOC3, RAB39A, and KNG1 for differentiating PR and IFC was superior to that of the conventional biomarkers and risk factors. The proteins (APOC3, RAB39A, and KNG1) serve as a potential novel diagnostic tool to identify PR in ACS patients. Show less
no PDF DOI: 10.1016/j.cca.2024.119904
APOC3